Want to see CVSA full AI Analyst Report?
CVSA Stock Chart & Stats
$136.38
$3.59(3.10%)
At close: 4:00 PM EDT
$136.38
$3.59(3.10%)
Day’s Range― - ―
52-Week Range$86.97 - $145.44
Previous CloseN/A
Volume76.09K
Average Volume (3M)326.47K
Market Cap
$4.36B
Enterprise Value$4.82B
Total Cash (Recent Filing)$406.32M
Total Debt (Recent Filing)$905.50M
Price to Earnings (P/E)16.4
Beta0.64
Next Earnings
Feb 02, 2027EPS Estimate
2.39Next Dividend Ex-DateN/A
Dividend Yield1.21%
Share Statistics
EPS (TTM)7.55
Shares Outstanding33,860,207
10 Day Avg. Volume272,697
30 Day Avg. Volume326,466
Financial Highlights & Ratios
PEG Ratio0.75
Price to Book (P/B)3.02
Price to Sales (P/S)2.24
P/FCF Ratio11.12
Enterprise Value/Market Cap1.10
Enterprise Value/Revenue2.46
Enterprise Value/Gross Profit4.30
Enterprise Value/Ebitda10.20
Forecast
1Y Price Target
$158.75Price Target Upside16.40% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)9.05
Revenue Forecast (FY)$2.07B
Bulls Say, Bears Say
Bulls Say
Revenue And Enrollment GrowthSustained enrollment gains across the platform are translating into durable revenue expansion and broader operating scale. Reaching 100,000 students, alongside 12 consecutive quarters of enrollment growth, supports continued market penetration and creates a stronger base for future earnings growth.
Cash Generation And LeverageStrong and improving cash generation gives Covista greater flexibility to fund campus expansion, technology investment, and shareholder returns without relying heavily on additional borrowing. The lower leverage position also improves resilience and reduces financial pressure as the business scales.
Employer-integrated EducationEmployer partnerships can make enrollment more durable by combining tuition support, clinical integration, and employment pathways. This model may improve persistence and completion while lowering acquisition costs, strengthening Covista's competitive position in healthcare education over time.
Bears Say
Margin VolatilityAlthough current profitability remains solid, the history of margin volatility and the recent step-down indicate that earnings conversion is not fully consistent. Higher costs or reinvestment demands could continue to limit margin expansion and make future profit growth less predictable.
Investment Pressure On MarginsElevated investment and capital spending can support long-term capacity, but they are likely to constrain near-term profitability and cash conversion. Delaying more of the expected margin improvement until the second half increases execution risk if expansion projects take longer to mature.
Higher Effective Tax RateA higher tax rate would reduce the portion of operating profit retained as net income, creating a structural headwind to earnings and cash generation even if revenue continues to grow. It may also limit the pace at which operating improvements translate into per-share results.
Covista News
CVSA FAQ
What was Covista’s price range in the past 12 months?
Covista lowest stock price was $86.97 and its highest was $145.44 in the past 12 months.
What is Covista’s market cap?
Covista’s market cap is $4.36B.
When is Covista’s upcoming earnings report date?
Covista’s upcoming earnings report date is Feb 02, 2027 which is in 95 days.
How were Covista’s earnings last quarter?
Covista released its earnings results on Oct 29, 2026. The company reported $2.19 earnings per share for the quarter, beating the consensus estimate of $1.832 by $0.358.
Is Covista overvalued?
According to Wall Street analysts Covista’s price is currently Undervalued.
Does Covista pay dividends?
Covista pays a Semiannually dividend of $0.18 which represents an annual dividend yield of 1.21%. See more information on Covista dividends here
What is Covista’s EPS estimate?
Covista’s EPS estimate is 2.39.
How many shares outstanding does Covista have?
Covista has 33,860,207 shares outstanding.
What happened to Covista’s price movement after its last earnings report?
Covista reported an EPS of $2.19 in its last earnings report, beating expectations of $1.832. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Covista?
Currently, no hedge funds are holding shares in CVSA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Covista Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$158.75 (16.40% Upside)
$158.75 (16.40% Upside)
Blogger Sentiment
Bullish
CVSA Sentiment 78%
Sector Average 62%
Sector Average 62%
Hedge Fund Trend
Decreased
By 271.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 7.3%
Last 30 Days ▼ 7.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-17.84%
12-Months-Change
Fundamentals
Return on Equity
17.82%
Trailing 12-Months
Asset Growth
13.76%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Covista
Adtalem Global Education, Inc. is an enterprise dedicated to providing higher education. The company organizes its operations into three primary divisions: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment delivers various degree and non-degree offerings within the nursing and broader health professions higher education sector. Through its Walden segment, the company offers extensive online learning options, including certificates, bachelor's, master's, and doctoral degrees in a wide range of subjects such as nursing, education, counseling, business, psychology, public health, social work, human services, public administration, public policy, and criminal justice. The Medical and Veterinary division provides both degree-granting and non-degree curricula tailored for post-secondary education in medicine and veterinary sciences. Dennis J. Keller and Ronald L. Taylor established the company in 1973, and its corporate headquarters are situated in Chicago, Illinois.
CVSA Company Deck
CVSA Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was strongly positive. Covista reported broad-based enrollment, revenue, EBITDA, EPS, cash flow, and balance-sheet improvements; exceeded fiscal 2026 guidance; launched a new growth strategy; and initiated fiscal 2027 guidance for continued revenue and EPS growth. The main challenges were stronger upcoming comparables, quarterly timing effects, a higher expected tax rate, investment-related timing of margin expansion, and some Medical & Veterinary enrollment pull-forward related to OB3 changes.View all CVSA earnings summariesCVSA Stock 12 Month Forecast
Average Price Target
$158.75
▲(16.40% Upside)
Technical Analysis
American Public Education
―
Perdoceo Education
―
Grand Canyon Education
―
Stride
―
Strategic Education
―
Ownership Overview
2.92% Insiders
40.49% Mutual Funds
0.71% Other Institutional Investors
25.07% Public Companies and
Individual Investors